AHL Partners LLP lessened its stake in shares of Zimmer Biomet Holdings, Inc. (NYSE:ZBH) by 37.5% during the second quarter, according to the company in its most recent disclosure with the SEC. The fund owned 58,874 shares of the medical equipment provider’s stock after selling 35,381 shares during the quarter. AHL Partners LLP’s holdings in Zimmer Biomet Holdings were worth $7,559,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently bought and sold shares of the business. BlackRock Inc. boosted its holdings in shares of Zimmer Biomet Holdings by 4.1% during the 2nd quarter. BlackRock Inc. now owns 17,419,463 shares of the medical equipment provider’s stock valued at $2,236,657,000 after acquiring an additional 679,080 shares in the last quarter. Vanguard Group Inc. grew its position in Zimmer Biomet Holdings by 2.6% during the 2nd quarter. Vanguard Group Inc. now owns 13,380,517 shares of the medical equipment provider’s stock worth $1,718,057,000 after acquiring an additional 339,106 shares during the last quarter. State Street Corp grew its position in Zimmer Biomet Holdings by 2.4% during the 1st quarter. State Street Corp now owns 8,193,165 shares of the medical equipment provider’s stock worth $1,000,463,000 after acquiring an additional 191,747 shares during the last quarter. Longview Partners Guernsey LTD grew its position in Zimmer Biomet Holdings by 4.4% during the 2nd quarter. Longview Partners Guernsey LTD now owns 6,377,711 shares of the medical equipment provider’s stock worth $818,898,000 after acquiring an additional 269,184 shares during the last quarter. Finally, Nordea Investment Management AB grew its position in Zimmer Biomet Holdings by 25.0% during the 1st quarter. Nordea Investment Management AB now owns 4,931,281 shares of the medical equipment provider’s stock worth $602,159,000 after acquiring an additional 987,398 shares during the last quarter. 85.36% of the stock is currently owned by hedge funds and other institutional investors.

In related news, VP Tony W. Collins sold 16,986 shares of the firm’s stock in a transaction on Monday, July 31st. The stock was sold at an average price of $121.74, for a total value of $2,067,875.64. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. 1.07% of the stock is owned by corporate insiders.

A number of brokerages have recently commented on ZBH. Royal Bank Of Canada lifted their price target on Zimmer Biomet Holdings from $133.00 to $140.00 and gave the company an “outperform” rating in a research note on Wednesday, June 21st. Bank of America Corporation reaffirmed a “buy” rating and issued a $158.00 price objective on shares of Zimmer Biomet Holdings in a research note on Friday, July 14th. BidaskClub downgraded Zimmer Biomet Holdings from a “buy” rating to a “hold” rating in a research note on Monday, July 24th. Piper Jaffray Companies reiterated a “buy” rating and issued a $135.00 price objective on shares of Zimmer Biomet Holdings in a report on Friday, July 28th. Finally, Zacks Investment Research lowered shares of Zimmer Biomet Holdings from a “hold” rating to a “sell” rating in a report on Tuesday, August 1st. Three equities research analysts have rated the stock with a sell rating, eight have issued a hold rating, thirteen have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. The company currently has an average rating of “Hold” and a consensus price target of $136.55.

TRADEMARK VIOLATION WARNING: This story was published by Watch List News and is owned by of Watch List News. If you are reading this story on another domain, it was illegally copied and republished in violation of United States & international trademark and copyright legislation. The correct version of this story can be accessed at https://www.watchlistnews.com/ahl-partners-llp-decreases-holdings-in-zimmer-biomet-holdings-inc-zbh/1607910.html.

Shares of Zimmer Biomet Holdings, Inc. (NYSE ZBH) traded up 0.125% during mid-day trading on Wednesday, hitting $116.295. 454,471 shares of the stock traded hands. The stock has a market cap of $23.51 billion, a price-to-earnings ratio of 33.123 and a beta of 1.19. The firm’s 50-day moving average is $114.59 and its 200-day moving average is $120.50. Zimmer Biomet Holdings, Inc. has a 52 week low of $95.63 and a 52 week high of $133.49.

Zimmer Biomet Holdings (NYSE:ZBH) last released its quarterly earnings data on Thursday, July 27th. The medical equipment provider reported $2.08 earnings per share for the quarter, missing the consensus estimate of $2.10 by ($0.02). The business had revenue of $1.95 billion during the quarter, compared to analysts’ expectations of $1.95 billion. Zimmer Biomet Holdings had a return on equity of 16.70% and a net margin of 9.12%. The company’s quarterly revenue was up 1.1% compared to the same quarter last year. During the same quarter last year, the business posted $2.02 EPS. On average, analysts forecast that Zimmer Biomet Holdings, Inc. will post $8.24 earnings per share for the current year.

The firm also recently announced a quarterly dividend, which will be paid on Friday, October 27th. Investors of record on Friday, September 22nd will be issued a dividend of $0.24 per share. The ex-dividend date of this dividend is Thursday, September 21st. This represents a $0.96 dividend on an annualized basis and a dividend yield of 0.83%. Zimmer Biomet Holdings’s dividend payout ratio is presently 27.59%.

Zimmer Biomet Holdings Company Profile

Zimmer Biomet Holdings, Inc is engaged in designing, manufacturing and marketing of orthopedic reconstructive products; sports medicine, biologics, extremities and trauma products; office-based technologies; spine, craniomaxillofacial and thoracic products; dental implants, and related surgical products.

Want to see what other hedge funds are holding ZBH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Zimmer Biomet Holdings, Inc. (NYSE:ZBH).

Institutional Ownership by Quarter for Zimmer Biomet Holdings (NYSE:ZBH)

Receive News & Ratings for Zimmer Biomet Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Zimmer Biomet Holdings Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.